Crispr Therapeutics call volume above normal and directionally bullish
The Fly

Crispr Therapeutics call volume above normal and directionally bullish

Bullish option flow detected in Crispr Therapeutics with 10,586 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 53.17%. 12/22 weekly 65 calls and Jan-24 55 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.24. Earnings are expected on February 20th.

Don't Miss out on Research Tools:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on CRSP:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App